바이오인

The Government of the United States (US) has long played a role in the development of new global health products that have transformed communities in the poorest countries in the world and saved the lives of millions. However, with increasing political pressure to scale back US Government investment in global health research and development (R&D) and focus instead on programs that further national security and demonstrate quick impacts, a review of evidence on the benefits of global health R&D investments and the cost-effectiveness of US Government funding is critical.